Akoya Biosciences Inc (AKYA)
2.85
-0.05
(-1.72%)
USD |
NASDAQ |
May 17, 16:00
2.85
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Cash from Operations (Quarterly): -20.82M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -20.82M |
December 31, 2023 | -5.584M |
September 30, 2023 | -13.75M |
June 30, 2023 | -11.80M |
March 31, 2023 | -19.76M |
December 31, 2022 | -10.01M |
September 30, 2022 | -12.17M |
June 30, 2022 | -13.39M |
March 31, 2022 | -17.93M |
Date | Value |
---|---|
December 31, 2021 | -5.854M |
September 30, 2021 | -13.40M |
June 30, 2021 | -12.42M |
March 31, 2021 | -4.404M |
December 31, 2020 | -2.147M |
September 30, 2020 | -1.74M |
June 30, 2020 | -1.999M |
March 31, 2020 | -0.957M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.82M
Minimum
Mar 2024
-0.957M
Maximum
Mar 2020
-9.89M
Average
-11.80M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
Azenta Inc | 8.356M |
Harvard Bioscience Inc | 1.403M |
Standard BioTools Inc | -62.48M |
Bionano Genomics Inc | -28.13M |
Singular Genomics Systems Inc | -23.70M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -48.82M |
Cash from Financing (Quarterly) | -0.444M |
Free Cash Flow | -55.62M |
Free Cash Flow Per Share (Quarterly) | -0.4398 |
Free Cash Flow to Equity (Quarterly) | -21.85M |
Free Cash Flow to Firm (Quarterly) | -19.95M |
Free Cash Flow Yield | -41.42% |